Union Bancaire Privee UBP SA acquired a new position in shares of Corteva, Inc. (NYSE:CTVA – Free Report) in the first quarter, according to its most recent filing with the Securities & Exchange Commission. The firm acquired 81,822 shares of the company’s stock, valued at approximately $6,849,000.
A number of other hedge funds and other institutional investors have also bought and sold shares of the company. Cambient Family Office LLC lifted its stake in Corteva by 8.6% in the 1st quarter. Cambient Family Office LLC now owns 5,929 shares of the company’s stock valued at $496,000 after acquiring an additional 469 shares in the last quarter. Rooted Wealth Advisors Inc. bought a new position in shares of Corteva during the 1st quarter worth approximately $226,000. Venturi Wealth Management LLC raised its holdings in shares of Corteva by 33.7% in the first quarter. Venturi Wealth Management LLC now owns 6,910 shares of the company’s stock valued at $578,000 after purchasing an additional 1,743 shares during the last quarter. Welch Group LLC acquired a new stake in shares of Corteva in the first quarter valued at approximately $249,000. Finally, Aaron Wealth Advisors LLC lifted its position in shares of Corteva by 30.8% in the first quarter. Aaron Wealth Advisors LLC now owns 8,168 shares of the company’s stock worth $684,000 after purchasing an additional 1,921 shares in the last quarter. Institutional investors and hedge funds own 81.54% of the company’s stock.
Wall Street Analysts Forecast Growth
CTVA has been the subject of a number of analyst reports. Jefferies Financial Group raised their target price on shares of Corteva from $95.00 to $97.00 in a research report on Thursday, May 7th. Oppenheimer lifted their target price on Corteva from $86.00 to $89.00 and gave the company an “outperform” rating in a research report on Wednesday, April 22nd. CICC Research raised their price target on Corteva from $80.00 to $93.00 and gave the company an “outperform” rating in a research note on Wednesday, May 13th. Deutsche Bank Aktiengesellschaft upped their price objective on Corteva from $90.00 to $100.00 in a research note on Monday, May 11th. Finally, Morgan Stanley raised their target price on shares of Corteva from $84.00 to $95.00 and gave the company an “overweight” rating in a research note on Thursday, May 28th. Fourteen analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $88.81.
Corteva Price Performance
NYSE:CTVA opened at $82.60 on Friday. Corteva, Inc. has a 12-month low of $60.53 and a 12-month high of $85.63. The firm has a market capitalization of $55.24 billion, a price-to-earnings ratio of 48.59, a P/E/G ratio of 2.50 and a beta of 0.57. The stock’s 50 day moving average price is $79.38 and its two-hundred day moving average price is $76.20. The company has a quick ratio of 1.03, a current ratio of 1.47 and a debt-to-equity ratio of 0.07.
Corteva (NYSE:CTVA – Get Free Report) last issued its earnings results on Tuesday, May 5th. The company reported $1.50 EPS for the quarter, topping the consensus estimate of $1.18 by $0.32. Corteva had a return on equity of 9.95% and a net margin of 6.50%.The company had revenue of $4.91 billion during the quarter, compared to the consensus estimate of $4.64 billion. During the same period in the previous year, the company posted $1.13 EPS. The firm’s revenue for the quarter was up 11.0% compared to the same quarter last year. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. On average, analysts anticipate that Corteva, Inc. will post 3.72 earnings per share for the current year.
Corteva Announces Dividend
The business also recently disclosed a quarterly dividend, which was paid on Monday, June 15th. Stockholders of record on Monday, June 1st were given a $0.18 dividend. The ex-dividend date of this dividend was Monday, June 1st. This represents a $0.72 annualized dividend and a dividend yield of 0.9%. Corteva’s dividend payout ratio is presently 42.35%.
About Corteva
Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.
Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.
Featured Articles
- Five stocks we like better than Corteva
- Rocket Lab’s NASA Win Tests Key Support After Sharp Pullback
- AST SpaceMobile Just Nailed a Major Launch—So Why Is the Stock Crashing?
- Palantir’s Valuation Problem Just Met 2 New Growth Catalysts
- Xcel Energy Stock Offers Stability as Electricity Demand Builds
Want to see what other hedge funds are holding CTVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Corteva, Inc. (NYSE:CTVA – Free Report).
Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.
